Skip to main content
. 2024 Mar 22;103(7):1348–1365. doi: 10.1111/aogs.14822

TABLE 3.

Clinical characteristics of the fertile group and recurrent implantation failure (RIF) group.

Fertile (n = 23) RIF (n = 23) P‐value
Female age, years 34.2 (± 4.4) 36.3 (± 3.9) 0.095
Female age groups 0.074
<35 years 13 (56.5%) 7 (30.4%)
≥35 years 10 (43.5%) 16 (69.6%)
Female BMI, kg/m2 23.0 (20.7–25.9) 23.7 (21.6–28.3) 0.560
Duration of infertility, months 26.0 (20.0–38.0) 29.0 (23.0–39.0) 0.403
Female smokers a 1 (4.3%) 1 (4.3%) 1.000
Type of infertility of the female b 0.552
Primary 14 (60.9%) 12 (52.2%)
Secondary 9 (39.1%) 11 (47.8%)
Cause of infertility c 1.000
Idiopathic 9 (39.1%) 8 (34.8%)
Male factor 13 (56.5%) 12 (52.2%)
Tubal factor 1 (4.3%) 2 (8.7%)
Ovulatory disorder d 0 1 (4.3%)
No. of embryo transfers per participant 2.4 (±0.5) 5.7 (±2.5) <0.001
1 15 (65.2%) 0
2 8 (34.8%) 0
3 0 5 (21.7%)
4 0 4 (17.4%)
5 0 3 (13.0%)
6 0 4 (17.4%)
7 0 1 (4.3%)
8 0 3 (13.0%)
9 0 2 (8.7%)
13 0 1 (4.3%)
Total no. of embryos transferred, all participants 60 153
No. of SET and DET 0.379
SET 46 (86.8%) 105 (81.4%)
DET 7 (13.2%) 24 (18.6%)
ET performed on day <0.001
2 0 2 (1.3%)
3 51 (85.0%) 78 (51.0%)
4 5 (8.3%) 42 (27.5%)
5 4 (6.7%) 29 (19.0%)
6 0 2 (1.3%)
No. of fresh and frozen‐thawed ETs <0.001
Fresh 52 (86.7%) 74 (48.4%)
Frozen‐thawed 8 (13.3%) 79 (51.6%)
Embryonic stage 0.005
Cleavage stage embryo 55 (91.7%) 109 (71.2%)
Morula 1 (1.7%) 14 (9.2%)
Blastocyst 4 (6.7%) 30 (19.6%)

Note: Data are presented as mean (± SD), median (IQR) or number (%). The P‐value indicating the difference between mean number of embryo transfers per participant was determined by Independent Samples T‐test. All other P‐values were determined by Chi square test.

Abbreviations: BMI, body mass index; DET, double embryo transfer; ET, embryo transfer; SET, single embryo transfer.

a

Data was missing for one participant in the RIF group.

b

Primary: female has never conceived before. Secondary: female has conceived before.

c

No specific infertility diagnoses were excluded.

d

The woman in the RIF group with an ovulatory disorder had a WHO group III ovulatory disorder.